MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 -
Germany
This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
English
Profile: MII PR MTB Antrag Kostenuebernahme version: 2027.0.0-ballot.1
status: Active
type: institutional
use: Claim
patient: Maxim Muster (no stated gender), DoB Unknown
created: 2024-07-07
provider: Organization Example General Hospital
priority: Normal
| Relationship |
| initial-claim |
prescription: MedicationRequest: status = active; intent = option; medication[x] = Dabrafenib; authoredOn = 2024-01-01
| Sequence | Provider | Responsible |
| 1 | Organization Example General Hospital | true |
| Sequence | Focal | Coverage |
| 1 | true | Coverage: status = active; type = extended healthcare; period = 2023-01-01 --> 2025-12-31 |